Amoeba S.A. | Cash Flow

Fiscal year is January-December. All values EUR Thousands.
2014
2015
2016
2017
Net Income before Extraordinaries
974.60
4,018.90
5,767.80
6,233.50
Depreciation, Depletion & Amortization
97.80
142.90
228.90
697.50
Other Funds
324.30
52.00
28.80
-
Funds from Operations
717.80
3,807.10
5,414.40
5,439.20
Changes in Working Capital
475.20
357.60
291.40
319.50
Net Operating Cash Flow
1,193.00
4,164.70
5,705.80
5,119.60
Capital Expenditures
893.10
2,188.70
3,349.50
892.40
Sale of Fixed Assets & Businesses
-
-
-
102.70
Purchase/Sale of Investments
-
-
-
34.30
Net Investing Cash Flow
892.90
2,442.00
3,364.80
856.60
Issuance/Reduction of Debt, Net
747.80
38.80
586.80
4,168.30
Net Financing Cash Flow
4,243.70
11,719.60
13,358.80
4,220.80
Net Change in Cash
2,157.20
5,112.70
4,265.50
1,758.00
Free Cash Flow
1,217.80
5,590.60
8,928.40
6,006.70
Other Sources
0.20
-
-
-
Change in Capital Stock
3,171.60
11,706.40
13,974.40
52.50
Exchange Rate Effect
0.60
0.30
22.70
2.60
Other Uses
-
253.30
15.30
101.10

About Amoeba

View Profile
Address
38, Avenue des frères Montgolfier
Lyon Rhone-Alpes 69680
France
Employees -
Website http://www.amoeba-biocide.com/fr
Updated 07/08/2019
Amoéba SA engages in developing, manufacturing and biological products. Its product includes biocide used against Legionella, amoeba and biofilm. The company was founded by Fabrice Plasson and Jacques Bodennec on July 21, 2010 and is headquartered in Lyon, France.